185 related articles for article (PubMed ID: 28029298)
1. Unintended Consequences in Cancer Care Delivery Created by the Medicare Part B Proposal: Is the Clinical Rationale for the Experiment Flawed?
Gordan L; Grogg A; Blazer M; Fortner B
J Oncol Pract; 2017 Feb; 13(2):e139-e151. PubMed ID: 28029298
[TBL] [Abstract][Full Text] [Related]
2. Medicare challenges and solutions--reimbursement issues in treating the patient with colorectal cancer.
Kaa K
J Manag Care Pharm; 2007 Aug; 13(6 Suppl C):S19-26. PubMed ID: 17713991
[TBL] [Abstract][Full Text] [Related]
3. Comparing the Cost of Caring for Medicare Beneficiaries in Federally Funded Health Centers to Other Care Settings.
Mukamel DB; White LM; Nocon RS; Huang ES; Sharma R; Shi L; Ngo-Metzger Q
Health Serv Res; 2016 Apr; 51(2):625-44. PubMed ID: 26213167
[TBL] [Abstract][Full Text] [Related]
4. Design Challenges of an Episode-Based Payment Model in Oncology: The Centers for Medicare & Medicaid Services Oncology Care Model.
Kline RM; Muldoon LD; Schumacher HK; Strawbridge LM; York AW; Mortimer LK; Falb AF; Cox KJ; Bazell C; Lukens EW; Kapp MC; Rajkumar R; Bassano A; Conway PH
J Oncol Pract; 2017 Jul; 13(7):e632-e645. PubMed ID: 28535101
[TBL] [Abstract][Full Text] [Related]
5. High Variation of Intravitreal Injection Rates and Medicare Anti-Vascular Endothelial Growth Factor Payments per Injection in the United States.
Erie JC; Barkmeier AJ; Hodge DO; Mahr MA
Ophthalmology; 2016 Jun; 123(6):1257-62. PubMed ID: 26976701
[TBL] [Abstract][Full Text] [Related]
6. Measuring the Value of New Medications and Implications for Medicare's Proposed Part B Drug Payment Model.
Hwang TJ; LaMattina JL
JAMA Oncol; 2016 Sep; 2(9):1125-6. PubMed ID: 27388928
[No Abstract] [Full Text] [Related]
7. Documentation of chemotherapy infusion preparation costs in academic- and community-based oncology practices.
Brixner DI; Oderda GM; Nickman NA; Beveridge R; Jorgenson JA
J Natl Compr Canc Netw; 2006 Mar; 4(3):197-208. PubMed ID: 16507268
[TBL] [Abstract][Full Text] [Related]
8. Receipt of chemotherapy among medicare patients with cancer by type of supplemental insurance.
Warren JL; Butler EN; Stevens J; Lathan CS; Noone AM; Ward KC; Harlan LC
J Clin Oncol; 2015 Feb; 33(4):312-8. PubMed ID: 25534387
[TBL] [Abstract][Full Text] [Related]
9. CMS proposal on Part B drugs deserves support.
Goozner M
Mod Healthc; 2016 Jul; 46(26-27):34. PubMed ID: 30480898
[TBL] [Abstract][Full Text] [Related]
10. Medicare Competitive Bidding Program.
Parkin CG
J Diabetes Sci Technol; 2017 Mar; 11(2):324-326. PubMed ID: 27491528
[TBL] [Abstract][Full Text] [Related]
11. CMS Wants to Remodel Cancer Payment, Care.
Reinke T
Manag Care; 2016 Oct; 25(10):12-15. PubMed ID: 28121537
[TBL] [Abstract][Full Text] [Related]
12. Centers for medicare and medicaid services: using an episode-based payment model to improve oncology care.
Kline RM; Bazell C; Smith E; Schumacher H; Rajkumar R; Conway PH
J Oncol Pract; 2015 Mar; 11(2):114-6. PubMed ID: 25690596
[TBL] [Abstract][Full Text] [Related]
13. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
Bazalo G; Weiss RC
Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986
[TBL] [Abstract][Full Text] [Related]
14. Trajectories of Injectable Cancer Drug Costs After Launch in the United States.
Gordon N; Stemmer SM; Greenberg D; Goldstein DA
J Clin Oncol; 2018 Feb; 36(4):319-325. PubMed ID: 29016226
[TBL] [Abstract][Full Text] [Related]
15. Variations in payment patterns for surgical care in the centers for Medicare and Medicaid Services.
Bergman J; Laviana AA; Kwan L; Lerman SE; Aronson WJ; Bennett CJ; Hu JJ
Surgery; 2017 Feb; 161(2):312-319. PubMed ID: 26922367
[TBL] [Abstract][Full Text] [Related]
16. Paying for Cancer Drugs That Prove Their Benefit.
Frank RG; Emanuel EJ
JAMA; 2021 Oct; 326(16):1579-1580. PubMed ID: 34633420
[No Abstract] [Full Text] [Related]
17. Reimbursing Wisely? CMS's Trial of Medicare Part B Drug Payment Reform.
Schrag D
N Engl J Med; 2016 Jun; 374(22):2101-5. PubMed ID: 27248616
[No Abstract] [Full Text] [Related]
18. Physician payment 2008 for interventionalists: current state of health care policy.
Manchikanti L; Giordano J
Pain Physician; 2007 Sep; 10(5):607-26. PubMed ID: 17876359
[TBL] [Abstract][Full Text] [Related]
19. Implications of Proposed Medicare Reforms to Counteract High Cancer Drug Prices.
Mailankody S; Prasad V
JAMA; 2016 Jul; 316(3):271-2. PubMed ID: 27149663
[No Abstract] [Full Text] [Related]
20. Physician payment outlook for 2012: déjà vu.
Manchikanti L; Singh V; Caraway DL; Benyamin RM; Falco FJ; Hirsch JA
Pain Physician; 2012; 15(1):E27-52. PubMed ID: 22270747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
